TT
Tate Deborah Taylor
Director

Tate Deborah Taylor insider trades: Healthstream (HSTM) stock sales

Director, Healthstream Last trade Nov 5, 2026 50 Form 4 filings
$146K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2013
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Tate reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 5, 2026HSTM↓ Sell$106K
Nov 26, 2025HSTM↓ Sell$40K
Aug 29, 2024HSTM↓ Sell$40K
Feb 24, 2023HSTM↓ Sell$85K
Aug 16, 2021HSTM↓ Sell$30K
Oct 31, 2019HSTM↓ Sell$184K
Mar 7, 2018HSTM↓ Sell$292K
Aug 15, 2016HSTM↓ Sell$36K
Aug 13, 2014HSTM↓ Sell$52K
Mar 11, 2013HSTM↓ Sell$81K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other HSTM insiders

Open-market trades in the last 12 months

About Tate Deborah Taylor's insider trades

Tate Deborah Taylor is a director at Healthstream (HSTM). Since Mar 11, 2013, Tate has reported no open-market purchases and 10 sales worth $947K on SEC Form 4. In the last 12 months: 2 sales ($146K).

Their filings also include option exercises (20 filings), grants and awards (16 filings), gifts (10 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HSTM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.